BRPI0417530B1 - Composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit - Google Patents

Composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit Download PDF

Info

Publication number
BRPI0417530B1
BRPI0417530B1 BRPI0417530-1A BRPI0417530A BRPI0417530B1 BR PI0417530 B1 BRPI0417530 B1 BR PI0417530B1 BR PI0417530 A BRPI0417530 A BR PI0417530A BR PI0417530 B1 BRPI0417530 B1 BR PI0417530B1
Authority
BR
Brazil
Prior art keywords
drug
containing layer
gestodene
characterized
estrogen
Prior art date
Application number
BRPI0417530-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Bracht Stefan
Dittgen Michael
Huber Petra
Langguth Thomas
Schenk Dirk
Original Assignee
Bayer Intellectual Property Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US52871803P priority Critical
Priority to EP03078881.4 priority
Priority to EP03078881 priority
Priority to US60/528,718 priority
Application filed by Bayer Intellectual Property Gmbh. filed Critical Bayer Intellectual Property Gmbh.
Priority to PCT/IB2004/052752 priority patent/WO2005058287A2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0417530(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of BRPI0417530A publication Critical patent/BRPI0417530A/pt
Publication of BRPI0417530B1 publication Critical patent/BRPI0417530B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
BRPI0417530-1A 2003-12-12 2004-12-10 Composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit BRPI0417530B1 (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US52871803P true 2003-12-12 2003-12-12
EP03078881.4 2003-12-12
EP03078881 2003-12-12
US60/528,718 2003-12-12
PCT/IB2004/052752 WO2005058287A2 (en) 2003-12-12 2004-12-10 Transdermal delivery system of hormones without penetration enhancers

Publications (2)

Publication Number Publication Date
BRPI0417530A BRPI0417530A (pt) 2007-03-13
BRPI0417530B1 true BRPI0417530B1 (pt) 2018-01-23

Family

ID=34702342

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417530-1A BRPI0417530B1 (pt) 2003-12-12 2004-12-10 Composição para a liberação transdérmica de hormônios sem a necessidade de melhoradores de penetração, sistema terapêutico transdérmico, e kit

Country Status (15)

Country Link
JP (1) JP4965263B2 (und)
KR (1) KR101168449B1 (und)
CN (1) CN1913878B (und)
AU (1) AU2004298930B2 (und)
BR (1) BRPI0417530B1 (und)
CA (1) CA2549916C (und)
CU (1) CU23868B1 (und)
EA (1) EA011160B1 (und)
EC (1) ECSP066694A (und)
IL (1) IL176112A (und)
MX (1) MXPA06006682A (und)
NO (1) NO341989B1 (und)
NZ (1) NZ548091A (und)
WO (1) WO2005058287A2 (und)
ZA (1) ZA200605713B (und)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502004000988D1 (de) 2003-02-21 2006-08-31 Schering Ag Uv-stabiles transdermales pflaster
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
FR2900048B1 (fr) * 2006-04-21 2012-11-16 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
ME02618B (me) 2010-09-06 2017-06-20 Bayer Ip Gmbh Transdermalni flasteri sa malom dozom i velikim oslobađanjem leka
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
NZ627242A (en) * 2012-01-27 2016-08-26 Agile Therapeutics Inc Transdermal hormone delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
EP0555360A1 (en) * 1990-10-29 1993-08-18 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
AU692944B2 (en) * 1994-11-18 1998-06-18 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable patch
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
JP4167750B2 (ja) * 1997-04-16 2008-10-22 久光製薬株式会社 経皮吸収用基剤及び該基剤を含有する経皮吸収製剤
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
EP1197212A4 (en) * 1999-07-01 2004-06-02 Hisamitsu Pharmaceutical Co Adhesive preparation for percutaneous absorption
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US20020106402A1 (en) * 2000-12-05 2002-08-08 Hartwig Rod Lawson Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

Also Published As

Publication number Publication date
BRPI0417530A (pt) 2007-03-13
ZA200605713B (en) 2008-01-08
CN1913878A (zh) 2007-02-14
IL176112D0 (en) 2006-10-05
CA2549916C (en) 2013-09-17
IL176112A (en) 2011-02-28
AU2004298930B2 (en) 2009-11-26
CU20100143A7 (es) 2011-10-31
WO2005058287A3 (en) 2006-03-02
JP2007513938A (ja) 2007-05-31
WO2005058287A2 (en) 2005-06-30
NO341989B1 (no) 2018-03-12
KR101168449B1 (ko) 2012-07-25
CA2549916A1 (en) 2005-06-30
KR20060128910A (ko) 2006-12-14
CN1913878B (zh) 2010-05-26
ECSP066694A (es) 2006-10-31
JP4965263B2 (ja) 2012-07-04
EA200601089A1 (ru) 2006-12-29
MXPA06006682A (es) 2006-08-11
NO20062594L (no) 2006-07-10
NZ548091A (en) 2009-12-24
AU2004298930A1 (en) 2005-06-30
CU23868B1 (es) 2013-03-27
EA011160B1 (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
AU659457B2 (en) Transdermal fertility control system and process
US7456159B2 (en) Enhanced drug delivery in transdermal systems
EP0848608B1 (en) Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
ES2414455T3 (es) Sistema terapéutico transdérmico para la administración de rivastigmina
US4788062A (en) Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US6071531A (en) Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
US5891462A (en) Composition for transdermal administration of an estrogen
US8329680B2 (en) Formulation
JP5044078B2 (ja) 紫外線遮蔽性の貼付剤
JP2960832B2 (ja) エストラジオールの投与システム
US5904931A (en) Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
DE69613463T3 (de) Filmbildende pharmazeutische zusammensetzungen zur transdermalen verabreichung
RU2140784C1 (ru) Содержащая эстрадиол трансдермальная терапевтическая система
AU678237B2 (en) Active substance-containing plaster
CA1313623C (en) Transdermal estrogen/progestin dosage unit, system and process
CN1142753C (zh) 睾酮给药的皮肤贴
AU677206B2 (en) The use of glycerin in moderating transdermal drug delivery
JP3238389B2 (ja) ゲストデン含有の経皮適用のための薬剤
JP2975684B2 (ja) 経皮避妊製剤、方法及びデバイス
DE69434537T2 (de) System für transdermale verabreichung mit niedrigem fluss für hochwirksame medikamente
US8221784B2 (en) Transdermal hormone delivery system: compositions and methods
KR100505171B1 (ko) 스테로이드안정성을개선하기위한약물수송조성물
CA2005714C (en) Transdermal estrogen/progestin dosage unit, system and process
EP1089722B1 (en) Matrix-type transdermal patch for steroid hormones
US5376377A (en) Transdermal contraceptive formulations, methods and devices

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 9/70, A61K 31/565, A61P 15/00

Ipc: A61K 9/70 (2011.01), A61K 31/565 (2011.01)

B25D Requested change of name of applicant approved

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE)

Free format text: NOME ALTERADO DE: SCHERING AKTIENGESELLSCHAFT

B25D Requested change of name of applicant approved

Owner name: BAYER PHARMA AKTIENGESELLSCHAFT (DE)

B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH. (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B07A Technical examination (opinion): publication of technical examination (opinion)
B06I Technical and formal requirements: publication cancelled
B09A Decision: intention to grant
B16A Patent or certificate of addition of invention granted